My watch list

Trilostane


Trilostane
Systematic (IUPAC) name
?
Identifiers
CAS number	13647-35-3
ATC code	H02CA01
PubChem	656583
DrugBank	APRD01276
Chemical data
Formula	C₂₀H₂₇N O₃
Mol. mass	329.433 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	8 hours
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status	Withdrawn (U.S.)
Routes	?

Trilostane is an inhibitor of 3 β-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.^[1] It was withdrawn from the United States market in April 1994.

Additional recommended knowledge

Recognize and detect the effects of electrostatic charges on your balance

Weighing the right way

Safe Weighing Range Ensures Accurate Results

References

^ Komanicky P, Spark RF, Melby JC. (1978). "Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis". Journal of Clinical Endocrinology and Metabolism 47 (5): 1042–1051. PMID 233687. Retrieved on 2007-06-17.

v • d • e Corticosteroids for systemic use (H02)
Mineralocorticoids	Aldosterone - Fludrocortisone - Desoxycortone
Glucocorticoids	Betamethasone - Dexamethasone - Fluocortolone - Methylprednisolone - Paramethasone - Prednisolone - Prednisone - Triamcinolone - Hydrocortisone - Cortisone - Prednylidene - Rimexolone - Deflazacort - Cloprednol - Meprednisone - Cortivazol
Anticorticosteroids	Trilostane